GENEVA, Sept. 18 -- RS ONCOLOGY, LLC (1 BroadwayCambridge, MA 02142) filed a patent application (PCT/US2025/018654) for "THIOSTREPTON THERAPIES, DOSING REGIMENS, PATIENT POPULATIONS, AND COMBINATION THERAPIES" on Mar 06, 2025. With publication no. WO/2025/188940, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NAUMOV, George, N. (52 High StreetBrookline, MA 02445), CUNNIFF, Brian (392 Browns Trace RoadJericho, VT 05465)

Abstract: Disclosed herein are methods of administering thiostrepton with anti-cancer agents to trea...